out with the old and in with the new, again?
DESCRIPTION
Out With the Old and In With the New, Again?. Out With the Old, In With the New. Current Standard of Care. NEUTRINO and FISSION SOF + RBV ± pegIFN for Treatment-naive Patients. NEUTRINO and FISSION SOF + RBV ± pegIFN for Treatment-naive Patients. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/1.jpg)
Out With the Old and In With the New, Again?
![Page 2: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/2.jpg)
Out With the Old, In With the New
![Page 3: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/3.jpg)
Current Standard of Care
![Page 4: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/4.jpg)
NEUTRINO and FISSION SOF + RBV ± pegIFN for Treatment-naive Patients
![Page 5: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/5.jpg)
NEUTRINO and FISSION SOF + RBV ± pegIFN for Treatment-naive Patients
![Page 6: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/6.jpg)
FUSIONSOF + RBV ± pegIFN in Treatment-experienced Patients With G2,3 HCV
![Page 7: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/7.jpg)
VALENCESOF + RBV for 12 Weeks or 24 Weeks in G2 or G3 HCV Infection
![Page 8: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/8.jpg)
QUEST 1 and 2Q80K Variant Adversely Affects SVR12 of SMV-based Therapy
![Page 9: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/9.jpg)
COSMOS SOF + SIM ± RBV for G1 HCV-infected Patients by Fibrosis Stage
![Page 10: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/10.jpg)
2014 AASLD HCV Treatment Guidelines
![Page 11: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/11.jpg)
ION-1On the Road to IFN-free Therapy for G1 HCV
Infection
![Page 12: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/12.jpg)
ION-3 8 Weeks or 12 Weeks of SOF/LDV for Treatment-
naive G1 HCV Infection
![Page 13: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/13.jpg)
ION-2SOF/LDV in G1 HCV-infected Patients Failing
PegIFN/RBV ± DAA
![Page 14: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/14.jpg)
HALLMARK-DUALPhase 3 Trial of the All-oral Regimen DCV + ASV
for G1b HCV Infection
![Page 15: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/15.jpg)
SAPPHIRE IABT-450/r/Ombitasvir + Dasabuvir (3D) + RBV
for G1 HCV Infection
![Page 16: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/16.jpg)
SAPPHIRE IIABT-450/r/Ombitasvir + Dasabuvir + RBV (3D)
G1 HCV
![Page 17: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/17.jpg)
TURQUOISE IIABT-450/r/Ombitasvir + Dasabuvir (3D) + RBV in
Cirrhosis
![Page 18: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/18.jpg)
The Past And Future of HCV Therapy
![Page 19: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/19.jpg)
Abbreviations
![Page 20: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/20.jpg)
Abbreviations (cont)
![Page 21: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/21.jpg)
Abbreviations (cont)
![Page 22: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/22.jpg)
References
![Page 23: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/23.jpg)
References (cont)
![Page 24: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/24.jpg)
References (cont)
![Page 25: Out With the Old and In With the New, Again?](https://reader030.vdocument.in/reader030/viewer/2022033104/56815eda550346895dcd7af8/html5/thumbnails/25.jpg)
References (cont)